Cytotoxic T lymphocytes (CTLs) play a key role in tumor surveillance, but their activity can be suppressed by immune checkpoints such as CTLA-4, which inhibits early T cell activation by binding to B7 molecules on antigen-presenting cells [15,16,17,18,19,20]. The gene discussed is CTLA4; the disease is neoplasm.